EYE 2.78% 18.5¢ nova eye medical limited

POTENTIAL RE-RATE CATALYST EVENT: RESULTS, page-99

  1. 1,293 Posts.
    lightbulb Created with Sketch. 256
    I would think to be used in the NHS it will need the approval of NICE (National institute of clinical excellence) which is a ridiculous name because all they're concerned about is saving money. When I worked in the UK I was amazed by some of their decisions.
    So it will all come down to money & how itrack advance stacks up cost wise to other options
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.